MedTrace Logo

Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France

NCT04934202 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-06-22

No results posted yet for this study

Summary

From July to September 2020, in a first uncontrolled cohort study, 478 patients who were hospitalized at Bicêtre hospital for COVID-19 and who survived were evaluated at 4 months (publication accepted at JAMA). The current project aims to bring together the means to continue this work during the 2nd epidemic wave.

Conditions

  • Sequelae
  • Fibrosis
  • Post-COVID Syndrome
  • Post-traumatic Stress Disorder

Interventions

OTHER

Teleconsultation

Teleconsulting physicians will subject patients to a standardized questionnaire that will look for the following symptoms: * General signs: Anorexia, fatigue, new hospitalization, weight loss, * Respiratory signs: recent dyspnoea, chest discomfort, chest pain, new cough, abnormal lung CT scan since discharge * Neurological signs: headache, paraesthesia, anosmia, limb paralysis * Digestive signs: abdominal pain, diarrhoea, constipation, nausea, vomiting Edition 2021 ◌ Cognitive signs using the Q3PC questionnaire (10): memory loss, slowness in reasoning, activity planning or problem solving, concentration, attention difficulties

OTHER

Outpatient clinic

During a day hospitalization planned during the teleconsultation, patients will benefit from the following multidisciplinary assessment. * General clinical examination * Assessment of the state of health * Respiratory assessment * Pulmonary CT assessment * Cognitive evaluation * Cardiological evaluation * Renal assessment * Immunological evaluation

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Tai PHAM · Bicêtre Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-05-05
Completion
2022-05-05

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04934202 on ClinicalTrials.gov